PATENT CLAIM ANALYSIS

Application Number: 16018603
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["424", "078310"]

Abstract:
The present invention concerns methods of treating systemic, regional, or local inflammation from a patient suffering or at risk of inflammation comprising administration of a therapeutically effective dose of a sorbent that sorbs an inflammatory mediator in said patient. In some preferred embodiments, the sorbent is a biocompatible organic polymer.

Claim (Index 1):
A method of treating systemic, regional, or local inflammation from a patient suffering inflammation, said method comprising administration of a therapeutically effective dose of a sorbent for an inflammatory mediator in said patient; wherein the sorbent is a biocompatible polymer;\n the biocompatible polymer comprising residues from one or more monomers selected from divnylbenzene and ethylvinylbezene, styrene, ethylstyrene, acrylonitrile, butyl methacrylate, octyl methacrylate, butyl acrylate, octyl acrylate, cetyl methacrylate, cetyl acrylate, ethyl methacrylate, ethyl acrylate, vinyltoluene, vinylnaphthalene, vinylbenzyl alcohol, vinylformamide, methyl methacrylate, methyl acrylate, trivinylbenzene, divinylnaphthalene, trivinylcyclohexane, divinylsulfone, trimethylolpropane trimethacrylate, trimethylolpropane dimethacrylate, trimethylolpropane triacrylate, trimethylolpropane diacrylate, pentaerythritol dimethacrylate, pentaerythritol trimethacrylate, pentaerythritol tetramethacrylate, pentaerythritol diacrylate, pentaerythritol triiacrylate, pentaerythritol tetraacrylate, dipentaerythritol dimethacrylate, dipentaerythritol trimethacrylate, dipentaerythritol tetramethacrylate, dipentaerythritol diacrylate, dipentaerythritol triacrylate, dipentaerythritol tetraacrylate, divinylformamide and mixtures thereof, the biocompatible polymer having a pore structure that the total pore volume of pore size in the range of 50 \u212b to 3000 \u212b is greater than 0.5 cc/g to 3.0 cc/g dry polymer; sorbent being administered orally, via a feeding tube, peritoneally, or rectally; wherein said inflammatory mediator comprises one or more of cytokines, enzymes, prostaglandins, eicosanoids, leukotrienes, kinins, inflammatory mediator associated with anaphylaxis, coagulation factors, endotoxins, enterotoxins, lipopolysaccharide, cell fragments, bile salts, fatty acids, phospholipids, interferon and immunomodulatory antibodies, biologics and drugs.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 94.0
- Lexical Diversity: 1.30952
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15635517', '13637775', '14238548', '13344166', '13506875']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7704512674648054
- 35 USC 102 Novelty (BERT): 0.5725366201430191
- Combined Prediction Score: 0.7506598027326268
- Mean Citation Score: 374.67719000000005
- Max Citation Score: 502.80475
- Similarity Product: 380.1837376488894

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test